In addition, treatment with recombinant IL-33 (rIL-33) or CM from glioma cells expressing IL-33 or ΔNLS IL-33 were capable of recruiting BMDM in vitro (Supplementary Fig. 3f, g). The gene discussed is IL33; the disease is central nervous system cancer.